PO-0641: Is altered fractionation superior to conventional fractionation during concurrent chemoradiation for NPC?  by Liu, Y.C. et al.
3rd ESTRO Forum 2015                                                                                                                                         S311 
 
Materials and Methods: Between June 2009 and January 
2014, 100 consecutive patients (pts) (90 men, 10 women; 
mean age 60 years, range: 36-80) with HNC, were included in 
the study. The primary tumor sites were: 18% oral cavity, 20% 
oropharynx, 12% hypopharynx, 11% nasopharynx, 37% larynx, 
2% paranasal sinuses. 5% were stage I, 7% stage II, 14% stage 
III, 61% stage IVa, 7% stage IVb and 6% stage IVc. All patients 
were staged according to the American Joint Committee of 
Cancer 7th edition. We performed a contrast-enhanced CT 
and a contrast-enhanced 18FDG PET-CT which was done in the 
specific radiotherapy patient positioning. Both exams were 
compared to analyze a change in the detection of the 
primary tumor or nodal disease by 18FDG PET-CT and 
therefore a modification in the target volume planning (PTV).  
Results: In 6 pts, distance metastases were detected so that 
the intent of the treatment changed into palliative. 
Synchronous tumors were detected in 8 pts. When we 
analyzed he primary tumor defined by the CT and compared 
to the 18FDG PET-CT, it varied in 27% of cases due to 
differences in extension: 16 % increased; 11 % decreased 
which implies a variation in the delineation of tumor-GTV (T-
GTV). Referring to the nodal detection, it globally varied in 
42% cases: 5% pts were down-staged (pts staged as N2c 
changed to N2a, N2b or N1) and 3% (Nx to N0) were in fact 
false positive. This implies a reduction in the size of the 
nodal GTV (N-GTV). On the other hand, there were 17% pts 
affected by nodal disease detected thanks to the 18FDG PET-
CT but not diagnosed by the basal CT. 3% pts were staged as 
N+ (N1, N2a or N2b) but turned out into N2c. Those findings 
required to enlarge the nodal GTV. 
Conclusions: Target volume delineation is crucial in the 
radiotherapy treatment. The detection of metastases, 
additional nodal disease or larger extension in primary tumor 
has a great impact on patient management. The modification 
of the T-GTV and N-GTV implies a variation in the prescribed 
dose that could be related with the disease outcome and the 
final quality of life. 
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Purpose/Objective: To compare the survival between altered 
fractionated (AF) and conventional fractionated (CF) 
radiotherapy during concurrent chemoradiotherapy (CCRT) 
for nasopharyngeal carcinoma (NPC). 
Materials and Methods: A total of 203 patients with 1988 
AJCC stage III and IV NPC were treated by CCRT and followed 
at least 5 years. Radiotherapy was delivered by either a CF 
(70-74 Gy/35-40 fractions/7-8 weeks) or AF (72-75 Gy/45 
fractions/6 weeks) schedule. Both arms received the same 
concurrent chemotherapy, consisting of 96-hour continuous 
infusion of cisplatin and 5-FU during the first and 5th weeks 
of radiotherapy. Survival analysis was estimated by the 
Kaplan-Meier method and compared by the log-rank test. 
Results: The patient characteristics between CF and AF 
groups showed similar distribution. The 5-year nasopharynx 
failure-free, neck failure-free, and distant metastasis failure-
free survival rates were 88% vs. 86% (P=0.7781), 95% vs. 93% 
(P=0.4176), 76% vs. 73% (P=0.4029) for CF and AF arms. The 
5-year rates of overall survival (64% vs. 62%, P=0.4812) and 
progression-free survival (67% vs. 63%, P=0.3829) also showed 
similar for both groups. 
Conclusions: Conventional and altered fractionated 
radiotherapy got similar survival outcome when CCRT 
strategy was used for NPC 
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Purpose/Objective: Decision of replanning to spare the 
parotid gland (PG) during the course of locally advanced head 
and neck cancer (LAHNC) IMRT may be guided by anatomical 
markers. The objectives of the study were to identify these 
markers and generate nomograms: 
- to estimate the PG dose at the fraction; 
- to predict the PG cumulated dose delivered during the full 
treatment. 
Materials and Methods: Eighteen patients received radical 
IMRT (70Gy) for LAHNC. Weekly CTs were used to delineate 
the anatomical structures, in particular the internal and 
external PG, and to calculate the dose distributions at the 
fraction. Mean PG cumulated doses were then estimated on 
the planning CT from the weekly CTs by using deformable 
image registration. PG overdose was calculated by the 
difference between the fraction dose or cumulated dose and 
the planned dose. Correlations between anatomical markers 
and PG overdose were searched. Prediction models 
considering the population variation were generated with 
those anatomical markers. Nomograms were then generated 
to easily estimate the PG overdose. Calibration plots have 
been generated. 
Results: A total of 61% of the PG had an overdose of 3.2 Gy 
(ranging from 0.3 to 10gy) and 39% of the PGs had an 
underdose of -2.3 Gy (ranging from -0.1 to -7.9gy). At the 
fraction, the following anatomical markers were correlated 
with PG overdose (nomogram below) (p=<0.01 and R²=0.72): 
- decrease of the thickness of the neck 
- decrease of the superficial lobe of the PG 
- increase of the deep lobe of the PG 
For the cumulated dose, the PG overdose could be predicted 
from parameters calculated from the first weekly CT 
